Fi3 FINANCIAL ADVISORS LLC Sells 60 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fi3 FINANCIAL ADVISORS LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 829 shares of the healthcare conglomerate’s stock after selling 60 shares during the quarter. Fi3 FINANCIAL ADVISORS LLC’s holdings in UnitedHealth Group were worth $419,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of UNH. Howard Capital Management Group LLC bought a new position in UnitedHealth Group in the third quarter valued at approximately $341,000. Principal Financial Group Inc. grew its position in shares of UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after acquiring an additional 180,479 shares during the period. Thompson Siegel & Walmsley LLC grew its position in shares of UnitedHealth Group by 8.0% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 1,443 shares of the healthcare conglomerate’s stock valued at $844,000 after acquiring an additional 107 shares during the period. Integrated Investment Consultants LLC grew its holdings in UnitedHealth Group by 49.4% during the third quarter. Integrated Investment Consultants LLC now owns 1,597 shares of the healthcare conglomerate’s stock worth $934,000 after purchasing an additional 528 shares during the period. Finally, Pacer Advisors Inc. raised its stake in UnitedHealth Group by 4.7% in the third quarter. Pacer Advisors Inc. now owns 68,980 shares of the healthcare conglomerate’s stock valued at $40,331,000 after buying an additional 3,120 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Finally, Oppenheimer upped their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Up 1.3 %

NYSE UNH opened at $517.72 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market capitalization of $473.57 billion, a PE ratio of 33.40, a PEG ratio of 1.37 and a beta of 0.62. The business has a fifty day moving average price of $510.19 and a two-hundred day moving average price of $547.47.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.83 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.